Cancer SCs (CSCs) are regarded as a source of heterogeneous tumor cells and are responsible for tumor initiation, metastasis, recurrence and therapy resistance. Although CSCs are somewhat similar to tissue SCs in that they are self-renewing, rare cell populations, their origin is still uncertain.
Accumulating evidence indicates that CSCs originate from SCs, progenitor cells or differentiated cells. However, these models have not been experimentally tested. It is possible that differentiated cells can benconverted into progenitor cells or CSCs during tumorigenesis, similar to the cell dedifferentiation that has been observed in haematopoietic systems.
In the new study, researchers found that the proliferating cell nuclear antigen-associated factor (PAF)-Wnt signalling axis converts normal epithelial cells into CSC-like (CSL) cells.
PAF was initially identified as a proliferating cell nuclear antigen interacting protein. PAF modulates translesion DNA synthesis, a DNA bypass process, by facilitating the switch of the translesion DNA synthesis polymerase.
In recent times, researchers found that PAF, as a co-factor of b-catenin transcriptional complex, positively modulates Wnt signalling. In this study, the results revealed that PAF is highly expressed in breast cancer cells and plays key roles in inducing mammary epithelial cell (MEC) plasticity and maintaining breast cancer cell stemness.
In MECs, ectopic expression of PAF induces anchorage-independent cell growth and breast CSC marker expression. In mouse models, conditional PAF expression induces mammary ductal hyperplasia.
Moreover, PAF expression endows MECs with a self-renewing capacity and cell heterogeneity generation via Wnt signalling. Conversely, ablation of endogenous PAF induces the loss of breast cancer cell stemness.
Further cancer drug repurposing approaches reveal that NVP-AUY922 downregulates PAF and decreases breast cancer cell stemness. These results unveil an unsuspected role of the PAF-Wnt signalling axis in modulating cell plasticity, which is required for the maintenance of breast cancer cell stemness.
http://www.nature.com/ncomms/2016/160204/ncomms10633/full/ncomms10633.html
Edited
Latest News
TB blood test which could d…
By newseditor
Posted 27 Mar
Propionate supplementation…
By newseditor
Posted 27 Mar
Role of human Kallistatin i…
By newseditor
Posted 26 Mar
Addressing both flu and COV…
By newseditor
Posted 26 Mar
How the brain senses body p…
By newseditor
Posted 26 Mar
Other Top Stories
Gene that promotes muscle strength during exercise
Read more
How the brain chooses between pain and profit
Read more
Air pollution and stress alter brain development and social behavio…
Read more
How the brain gathers threat cues and turns them into fear
Read more
Immune tolerance of food is mediated by layers of CD4+ T cell dysfu…
Read more
Protocols
All-optical presynaptic pla…
By newseditor
Posted 23 Mar
Epigenomic tomography for p…
By newseditor
Posted 20 Mar
A mouse DRG genetic toolkit…
By newseditor
Posted 17 Mar
An optogenetic method for t…
By newseditor
Posted 13 Mar
Profiling native pulmonary…
By newseditor
Posted 08 Mar
Publications
Integrated plasma proteomic…
By newseditor
Posted 27 Mar
APP antisense oligonucleoti…
By newseditor
Posted 27 Mar
Targeting Erbin-mitochondri…
By newseditor
Posted 27 Mar
Regulation of Zbp1 by miR-9…
By newseditor
Posted 27 Mar
Pain-free oral delivery of…
By newseditor
Posted 27 Mar
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar